+ All Categories
Home > Documents > Zamai GIC 2010 How NK Cells Influence Desease

Zamai GIC 2010 How NK Cells Influence Desease

Date post: 07-Apr-2018
Category:
Upload: shamana82
View: 222 times
Download: 0 times
Share this document with a friend

of 42

Transcript
  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    1/42

    How NK cells influence disease

    Loris ZamaiLoris Zamai

    Department of human, environmental andDepartment of human, environmental andnatural Sciences;natural Sciences;

    Cytometry and Cytomorphology Center,Cytometry and Cytomorphology Center,University of Urbino;University of Urbino;

    INFN LNGS Assergi, LAquilaINFN LNGS Assergi, LAquila

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    2/42

    Natural Killer CellsNatural Killer Cells

    Site of generation:Site of generation: Bone marrow (lymph nodes ...)Bone marrow (lymph nodes ...) Morphology:Morphology:Large granular lymphocytesLarge granular lymphocytes

    Phenotype:Phenotype:CD56CD56++, CD16, CD16++, CD161, CD161++, IL-2R, IL-2R,, TCRTCR--, sIg, sIg--;;

    Inhibitory receptors : KIRInhibitory receptors : KIR++, CD94/NKG2A;, CD94/NKG2A;

    Activatory receptors: NCRs, NKG2D, 2B4Activatory receptors: NCRs, NKG2D, 2B4

    Function:Function:11..Cytotoxic activity mediated by lytic proteinCytotoxic activity mediated by lytic protein(perforin and granzymes) secretion or by(perforin and granzymes) secretion or bysurface molecules (FasL and TRAIL)surface molecules (FasL and TRAIL)without prior sensitization (vs. tumor andwithout prior sensitization (vs. tumor andvirus-infected cells)virus-infected cells)

    22.. Cytokine secretion (IFN-Cytokine secretion (IFN-, TNF-, TNF-,,GM-CSF, IL-5 etc.)GM-CSF, IL-5 etc.)

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    3/42

    Cytokine secretion

    TNF- GM-CSFIFN- IL-5

    TRAIL (inducible)/TRAIL-Rs

    Fas-L (inducible) /Fas

    (Ca2+-independent)

    Granule exocytosis

    (Ca2+-dependent)

    PerforinGranzymes

    Target:

    Necrosis

    Apoptosis

    Target:

    Cytostasis

    Differentiation

    Death

    Cytotoxic activity and cytokine production

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    4/42

    CD56dimcells are highly cytotoxic preferentially

    express KIRs and CD16 (that mediate antiboby

    dependent cell cytotoxicity, ADCC) and are

    preferentially activated after target cell recognition

    CD56brightcells produce high amounts of cytokines and

    preferentially express CD94-NKG2A inhibitory

    receptors and CD117 (c-kit), CD25 (IL-2 receptor alfa

    chain), CD62L, CCR7 (lymph node homing receptor)

    and are preferentially activated via cytokines (DC-

    derived IL-15, IL-12 and T cell-derived IL-2)

    Similar to CD8 and CD4 T cells, NK cells

    can be divided in two different subsets

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    5/42

    Peripheral blood NK cell subsetsCD56dim

    95% of PB NK cells

    More mature?

    highly cytotoxic

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    6/42

    Peripheral blood NK cell subsetsCD56bright

    5% of PB NK cells,

    are present in the

    lymph nodes

    more immature?

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    7/42

    NK Cell FunctionsNK Cell FunctionsNK and LAK (lymphokine activated killer)cells can kill via different mechanisms

    NKR

    NK cellfunctions areregulated byactivatoryandinhibitoryreceptors

    (NKR)

    NCRs,NKG2D

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    8/42

    NK cells express a lot NKdifferent activating receptors

    Moretta L and A, EMBO,2004, 23, 255

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    9/42

    human NK cells engaged by theirhuman NK cells engaged by their

    ligands on targetsligands on targets

    Activation via ITAM induces Vav1 phosphorilation

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    10/42

    receptors are expressed byreceptors are expressed by

    human NK cellshuman NK cells

    Bryceson et al. (2006) Immunol. Rev.

    ITIM recruit aphosphatase, SHP-1,

    that dephosphorilatesVav1, blocking allactivatory pathways

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    11/42

    (lectin-like and(lectin-like and

    immunoglobulin-like)immunoglobulin-like)

    expressed on subsets of NKexpressed on subsets of NKcellscells

    CD158eCD158

    Killer Ig-likereceptors(KIRs) with 2 or 3

    Ig-like domainsKIR2DL andKIR3DL

    HeterodimericreceptorCD94/NKG2A,B

    There are also

    activating version

    KIR2DS and KIR3DS

    with a shortintracytoplasmic tail

    There are also

    activating version

    CD94/NKG2C and E

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    12/42

    --receptors on human NK cells (KIR,receptors on human NK cells (KIR,

    CD94/NKG2A) binds to different HLACD94/NKG2A) binds to different HLA

    oligomorphic epitopesoligomorphic epitopes

    CD158e

    CD158b

    CD158a

    Recruitment of SHP-1 phosphatase via ITIM induces Vav1

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    13/42

    Activatory signals fromactivating receptors are

    blocked by HLA class Iinhibitory receptors engaged

    by self HLA molecules

    Missing self recognition

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    14/42

    Missing self recognition of NK cells can

    occur in haploidentical hematopoietic stem

    cell transplantation

    Velardi et al. 2008

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    15/42

    Selection of donor NK cells with donor versus

    recipient alloreactivity improves haploidentical

    hematopoietic stem cell transplantation

    Moretta et al. 2009

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    16/42

    Selection of donor NK cells with donor

    versus recipient alloreactivity :

    involvement of activating KIR (KIR2DS1)

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    17/42

    MHC-IMHC-I

    TCR-1

    TCR-1

    KIR

    CD94/NKG2A

    NO LYSIS

    NO LYSIS

    LYSIS

    LYSIS

    NKG2DNKG2D

    NCRNCR

    NCRNCR

    NKG2DNKG2D

    ULBPsMICA/B

    ULBPs

    MICA/B

    Complementary role of T and NK cells inMHC-driven cell cytotoxicity: self-MHC-I

    inhibits (NK), activates (T)

    CD94/NKG2A

    KIR

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    18/42

    NK cells act early during immune

    response before the activation of CTLs

    responsible for virus eradication

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    19/42

    Evidence of long lasting control of

    some diseases performed by NK cells

    depending on KIRs/HLA-I pairs

    Some KIRs/HLA-I pairs protect from:

    1) virus progression

    2) tumor progression

    Finally some KIRs-HLA-I pairs predispose to

    autoimmunity

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    20/42

    killer immunoglobulin-like receptors

    KIRs

    recognize oligomorphic regions of HLA-I

    molecule (KIR-ligand).

    evolutively recent molecules

    (mice do not expressed KIRs but lectin-like,

    Ly49 molecules with similar function but

    different structure)

    probably specialized to fight new evolved

    diseases (i.e. HIV)

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    21/42

    Evidences that some KIR/HLA-I

    pairs give protection against virus

    Cytomegalovirus (CMV)

    Human immunodeficiency

    virus (HIV) Hepatitis C virus (HCV)

    Fi t id th t NK ll t t

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    22/42

    First evidence that NK cells protects

    from virus (CMV) progression in mice

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    23/42

    Similar to CMV in mouse, an activatory

    KIR give protection from AIDS

    progression in humans

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    24/42

    Some KIR/HLA-I pairs protect from

    AIDS progression

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    25/42

    Some KIR/HLA-I pairs protect from HIV

    replication in vitro

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    26/42

    Some KIR/HLA-I pairs (KIR2DL3/HLA-

    C1) protect from HCV progression

    Intriguingly,KIR2DL3 has a

    low affinity for its

    ligand, HLA-C1

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    27/42

    And NK cells can recognize peptides on

    HLA-C1

    a possibility of a masking self recognition when a viral

    peptide is mounted on HLA-I, in particular in KIR/HLA-I

    pairs with low affinity binding (KIR2DL3/HLA-C1)

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    28/42

    Cervical neoplasia

    Melanoma

    Leukaemia

    Evidences that some KIR/HLA-I

    pairs give protection against tumor

    progression

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    29/42

    Some KIR-HLA-I pairs give protection

    from cervical neoplasia

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    30/42

    Some KIR-HLA-I pairs give protection

    from malignant melanoma

    Expansion of some NK (CD158a+) cells from

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    31/42

    Expansion of some NK (CD158a+) cells from

    melanoma patients expressing the

    corresponding HLA-C ligand, suggests their

    involvement in the control of the disease

    Some KIRs predispose to leukaemia

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    32/42

    Some KIRs predispose to leukaemia

    development

    May some other KIRs protect from leukaemia?

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    33/42

    NK cells and predisposition to

    autoimmune diseases

    Psoriatic ArthritisAnkylosing Spondylitis

    DiabetesMultiple sclerosis

    S KIR/HLA I i di t

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    34/42

    Some KIR/HLA-I pairs predispose to

    psoriatic arthritis

    Some KIR HLA I pairs predispose to

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    35/42

    Some KIR-HLA-I pairs predispose to

    ankylosing spondylitis

    Some KIR/HLA I pairs predispose to

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    36/42

    Some KIR/HLA-I pairs predispose to

    diabetes

    S KIR/HLA I i di t

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    37/42

    Some KIR/HLA-I pairs predispose to severe

    Multiple sclerosis

    Si il t T NK ll b

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    38/42

    Similar to T, NK cells can be

    activated by DC

    Moreover NK cells with

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    39/42

    Moreover . NK cells with

    Memory function

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    40/42

    Memory NK cells

    Fi ll NK ll ff t f

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    41/42

    Finally, NK cells as effectors of

    vaccine-induced immunity

  • 8/3/2019 Zamai GIC 2010 How NK Cells Influence Desease

    42/42

    Conclusions: in some cases NK cellsseems to do a job similar to CTLs

    Depending on:

    1) the disease (relatively new pathogens);

    2) the HLA-I (KIR ligand and/or TcR ligand) and

    3) the KIRs expressed by the subjects

    it can be predisposed a NK cell:

    1) immunosurveillance of viral-infected or cancer

    cells 2) autoimmune response

    A possible complementary role of T and NK


Recommended